What is the 13F Pro Quality Score for USNA?

13F Pro ranks USANA HEALTH SCIENCES INC (USNA) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View USNA's current score at https://13fpro.ai/company/USNA (free sign-up required for the full ranking).

Where does 13F Pro source USNA data?

All USANA HEALTH SCIENCES INC fundamentals and ownership data come directly from SEC EDGAR. USANA HEALTH SCIENCES INC files with the SEC under CIK 896264. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is USNA in?

USANA HEALTH SCIENCES INC (USNA) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is USNA research updated on 13F Pro?

USNA's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

USANA HEALTH SCIENCES INC(USNA)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSEsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 896264 USNA stock profile & AI dashboard →

13F Pro Quality Score

38.4/100

Rank #2,195 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

28.0/100

Profitability

24.1/100

Balance Sheet

26.2/100

Earnings Quality

68.1/100

Free Cash Flow

31.6/100

Institutional Flow

77.6/100

Revenue Scale

48.7/100

Dilution Risk

46.4/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why USNA Scores 38/100

exact factor attribution · 2026-09-11

USNA's composite is driven by earnings quality and institutional flow, held back by revenue growth and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

+1.8 pts

68th pct

Institutional flow

+1.4 pts

78th pct

Shareholder dilution

-0.2 pts

46th pct

Scale

-0.2 pts

49th pct

Earnings growth

-1.0 pts

29th pct

Capital efficiency

-2.4 pts

26th pct

Free cash flow

-2.8 pts

32th pct

Profitability

-3.9 pts

24th pct

Revenue growth

-4.4 pts

28th pct

Latest change (2026-08-13): 40 → 35 · ↓ Capital efficiency 56→28

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

USNA Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for USANA HEALTH SCIENCES INC (USNA), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores USNA at 38.4/100 on a 32-signal composite quality model, placing it at rank #2,195 of 2,962 stocks — the bottom half of the AI-ranked universe. USNA scores in the top quartile across institutional flow (77.6). Areas of concern include profitability (24.1) and balance sheet strength (26.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), USANA HEALTH SCIENCES INC reports quarterly revenue of $223.3M, net income of $-21.4M, free cash flow of $20.2M. Top institutional holders of USNA by reported 13-F value include BlackRock, PZENA INVESTMENT MANAGEMENT, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. USNA trades on the NYSE exchange and files with the SEC under CIK 896264. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate USNA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for USANA HEALTH SCIENCES INC directly from SEC EDGAR. USANA HEALTH SCIENCES INC's 13F Pro composite quality score has ranged between 35 and 61 since 2021, currently 38.4 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.

Revenue

Q2 2026

$223.3M

Net Income

Q2 2026

$-21.4M

Free Cash Flow

Q2 2026

$20.2M

ROIC

Q2 2026

-15.2%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+8.3% YoY

$925.3MFY 2025

FY22 $998.6MFY23 $921.0MFY24 $854.5MFY25 $925.3M

Net Income

-74.4% YoY

$10.8MFY 2025

FY22 $69.3MFY23 $63.8MFY24 $42.0MFY25 $10.8M

Operating Income

-43.6% YoY

$37.4MFY 2025

FY22 $107.6MFY23 $93.1MFY24 $66.3MFY25 $37.4M

EPS (Diluted)

-73.5% YoY

$0.58FY 2025

FY22 $3.59FY23 $3.30FY24 $2.19FY25 $0.58

Total Assets

-0.7% YoY

$742.9MFY 2025

FY22 $596.5MFY23 $632.8MFY24 $748.2MFY25 $742.9M

Op. Cash Flow

-63.4% YoY

$22.3MFY 2025

FY22 $103.9MFY23 $70.6MFY24 $61.0MFY25 $22.3M

Free Cash Flow

-83.3% YoY

$8.5MFY 2025

FY22 $93.5MFY23 $56.1MFY24 $50.9MFY25 $8.5M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$925.3M +8.3%	$854.5M -7.2%	$921.0M -7.8%	$998.6M -15.8%	$1.19B +4.6%	$1.13B
Net Income	$10.8M -74.4%	$42.0M -34.1%	$63.8M -8.0%	$69.3M -40.5%	$116.5M -6.5%	$124.7M
Operating Income	$37.4M -43.6%	$66.3M -28.7%	$93.1M -13.5%	$107.6M -36.8%	$170.2M -3.6%	$176.5M
EPS (Diluted)	$0.58 -73.5%	$2.19 -33.6%	$3.30 -8.1%	$3.59 -37.3%	$5.73 -2.2%	$5.86
Total Assets	$742.9M -0.7%	$748.2M +18.2%	$632.8M +6.1%	$596.5M +3.3%	$577.7M -9.9%	$640.9M
Operating Cash Flow	$22.3M -63.4%	$61.0M -13.7%	$70.6M -32.0%	$103.9M -14.3%	$121.2M -24.4%	$160.4M
Free Cash Flow	$8.5M -83.3%	$50.9M -9.3%	$56.1M -40.0%	$93.5M -13.8%	$108.5M -25.4%	$145.3M

Get alerted when USNA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for USANA HEALTH SCIENCES INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of USNA

BlackRock, Inc.
$33.2M1,554,189 sh
PZENA INVESTMENT MANAGEMENT LLC
$25.7M1,205,587 sh
RENAISSANCE TECHNOLOGIES LLC
$20.5M958,520 sh
DIMENSIONAL FUND ADVISORS LP
$17.9M837,426 sh
Nantahala Capital Management, LLC
$17.3M810,074 sh
VANGUARD CAPITAL MANAGEMENT LLC
$10.4M487,370 sh
Creative Planning
$8.9M417,971 sh
AQR CAPITAL MANAGEMENT LLC
$8.7M408,086 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$7.8M363,377 sh
GEODE CAPITAL MANAGEMENT, LLC
$6.0M283,165 sh

Fund	Value	Shares
BlackRock, Inc.	$33.2M	1,554,189
PZENA INVESTMENT MANAGEMENT LLC	$25.7M	1,205,587
RENAISSANCE TECHNOLOGIES LLC	$20.5M	958,520
DIMENSIONAL FUND ADVISORS LP	$17.9M	837,426
Nantahala Capital Management, LLC	$17.3M	810,074
VANGUARD CAPITAL MANAGEMENT LLC	$10.4M	487,370
Creative Planning	$8.9M	417,971
AQR CAPITAL MANAGEMENT LLC	$8.7M	408,086
VANGUARD PORTFOLIO MANAGEMENT LLC	$7.8M	363,377
GEODE CAPITAL MANAGEMENT, LLC	$6.0M	283,165

Companies Similar to USNA

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

AVNS

AVANOS MEDICAL, INC.

AI score

Similar quality profile · 4 shared holders

ROYCE & ASSOCIATES LP LSV ASSET MANAGEMENT BARROW HANLEY MEWHINNEY & STRAUSS LLC

ORGO

Organogenesis Holdings Inc.

AI score

Similar quality profile · 2 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC Verdad Advisers, LP

INNV

InnovAge Holding Corp.

AI score

Similar quality profile · 2 shared holders

Verdad Advisers, LP OCCUDO QUANTITATIVE STRATEGIES LP

TRUP

TRUPANION, INC.

AI score

Similar quality profile · 3 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC Numerai GP LLC Investors Portfolio Services LLC

OFIX

Orthofix Medical Inc.

AI score

Similar quality profile · 1 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC

NVCR

NovoCure Ltd

AI score

Similar quality profile · 4 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC Numerai GP LLC MEEDER ASSET MANAGEMENT INC

INGN

Inogen Inc

AI score

Similar quality profile · 1 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC

ANGO

ANGIODYNAMICS INC

AI score

Similar quality profile · 4 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC ROYCE & ASSOCIATES LP SEGALL BRYANT & HAMILL, LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put USNA on your watchlist

Track score changes the day USANA HEALTH SCIENCES INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is USNA a good stock to buy?

13F Pro's AI-powered analysis of USANA HEALTH SCIENCES INC (USNA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for USNA are available on the USNA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. USNA is classified as a small company.

Which hedge funds own USNA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling USNA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of USANA HEALTH SCIENCES INC's investment landscape.